Ultima Genomics
PrivateLast Round
Early Funding
May 31, 2022
Total Funding Raised
$604.45M
Company Overview
Ultima Genomics is a biotechnology company that develops and manufactures high-throughput, low-cost genome sequencing platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ultima Genomics Comparables
Compare Ultima Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Element Biosciences | 88% | |
| MGI | 78% | |
| GeneMind Biosciences Co., Ltd. | 77% | |
Ultima Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 31, 2022 | ||||
| Grant | Apr 1, 2021 |
Secondary Market Activity
Bids, offers, and trades by month
| Operation | Date | Price | Size | Share Class | Structure |
|---|---|---|---|---|---|
OFFER |
Key People
Founding team and executive leadership
Ultima Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Early Funding |
| Khosla Ventures | Early Funding, Seed |
| NIH RADx | Grant |
| Playground Global | Early Funding |
| Founders Fund | Early Funding |
| D1 Capital Partners | Early Funding |
| aMoon | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 26, 2026
Launched the UG200 Series, a next-generation sequencing platform.
- Feb 25, 2026
Presented technologies at the AGBT Conference on February 25, 2026.
Ultima Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ultima Genomics's valuation, stock price, and market status.